(“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 million) in its Series E ...

Owlstone Medical has secured the first closing of its Series E financing round, securing $27m (approximately £22m) to advance ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

Owlstone Medical, the Cambridge-based global leader in Breath Biopsy® for applications in early disease detection and ...

Lindner says NCH is the first Florida hospital to get this biopsy tool, providing results in as little as two minutes. It also allows pathologists, the individuals who would typically analyze the ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

What is fatty liver disease? The most common liver disorder in the United States, nonalcoholic fatty liver disease (NAFLD) is ...

The UK’s first liver transplant for advanced bowel cancer has been hailed a success - but what are the warning signs for the ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for early cancer detection. This investment increases OXcan's total funding to ...

Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist ...